Skip to main content

A man enters the Tel Aviv Stock Exchange on Jan. 29, 2017.

Baz Ratner/Reuters

The Tel Aviv Stock Exchange transformed into a public company on Thursday after completing a long awaited initial public offering that valued the bourse at 710 million shekels ($202 million).

Joining a global trend, the Israeli exchange sold nearly 32 per cent of its shares at 7.1 shekels per share. They jumped 30 per cent in their first hours of trading to 9.25 shekels in heavy turnover.

The TASE, founded 66 years ago, said the IPO drew demand from institutions, mostly global investors.

Story continues below advertisement

Itai Ben-Zeev, the TASE’s chief executive, said the bourse will operate more transparently and responsibly.

“We hope we have paved the way for other Israeli companies seeking to issue on the Tel Aviv Stock Exchange with an offering that includes large international investment entities alongside local investors,” he said.

“Such a global offering has many benefits to Israeli companies in terms of their valuation and the diversity and number of investors.”

Last year, TASE – which has lost 40 per cent of investors since 2010 – sold nearly a 20 per cent stake to investment fund Manikay Partners and another 19 per cent to four other foreign investors. That sale valued the exchange at 551 million shekels.

With 447 traded companies at a market value of $215 billion, the TASE has been struggling with delistings and declining trading volumes.

In the first half of 2019, daily trading averaged 1.2 billion shekels.

The TASE earned 5.4 million shekels in the first quarter, down from 8.1 million a year earlier, citing lower revenue and higher expenses. Revenue slipped 2 per cent to 64.6 million shekels.

Story continues below advertisement

It plans to distribute 30-50 per cent of its ongoing profit starting in 2020 as a dividend.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter